Patti E Gravitt

Title: Patti E Gravitt: Innovator in HPV Detection

Introduction

Patti E Gravitt is a notable inventor based in Oakland, CA (US). She has made significant contributions to the field of molecular diagnostics, particularly in the detection of human papillomavirus (HPV). With a total of 2 patents, her work has advanced the understanding and detection of HPV, which is crucial for public health.

Latest Patents

One of her latest patents focuses on the detection of human papillomavirus by the polymerase chain reaction (PCR). This method allows for the amplification of HPV DNA sequences, enabling the identification and typing of HPV present in a sample. The use of consensus primers facilitates the amplification of specific regions of the HPV genome. The presence of HPV is indicated by the formation of amplified DNA, which is then detected using consensus probes. Additionally, type-specific DNA probes are employed to accurately type the HPV based on the amplified DNA region.

Career Highlights

Throughout her career, Patti has worked with prominent companies in the biotechnology sector, including Roche Molecular Systems, Inc. and Hoffmann-La Roche Inc. Her experience in these organizations has contributed to her expertise in molecular diagnostics and HPV detection.

Collaborations

Patti has collaborated with esteemed colleagues such as Robert M Resnick and Catherine E Greer. These partnerships have further enriched her research and development efforts in the field of HPV detection.

Conclusion

Patti E Gravitt's innovative work in HPV detection through PCR has made a significant impact on molecular diagnostics. Her contributions continue to influence the field and enhance public health initiatives.